| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |